A magic drug target: Androgen receptor
Author:
Affiliation:
1. College of Pharmaceutical Sciences, Zhejiang University; Hangzhou Zhejiang China
2. State Key Lab of CAD&CG, Zhejiang University; Hangzhou Zhejiang China
3. School of Life Science, Huzhou University; Huzhou China
Funder
National Key R&D Program of China
National Natural Science Foundation of China
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/med.21558/fullpdf
Reference159 articles.
1. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors;Lu;Pharmacol Rev,2006
2. Androgen receptor phosphorylation: biological context and functional consequences;Koryakina;Endocr Relat Cancer,2014
3. Androgen receptor: structure, role in prostate cancer and drug discovery;Tan;Acta Pharmacol Sin,2015
4. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer;Watson;Nat Rev Cancer,2015
5. Molecular determinants of resistance to antiandrogen therapy;Chen;Nat Med,2004
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer;Oncogene;2024-09-13
2. Evaluation of androgen receptor and androgen receptor splice-variant 7 in bladder cancer; a novel approach into an ancient topic;World Journal of Urology;2024-07-31
3. Effects of testosterone dose on depression-like behavior among castrated adult male rats;Psychoneuroendocrinology;2024-07
4. Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer;Translational Oncology;2024-06
5. A potent new-scaffold androgen receptor antagonist discovered on the basis of a MIEC-SVM model;Acta Pharmacologica Sinica;2024-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3